– August 1, 2009
August 1, 2009
View Archives Issues
-
Ultrasound Treatment for Prostate Cancer: Finding the Middle Ground
The experience of two referral centers in London, UK, on the short-term outcomes of high-intensity-focused ultrasound (HIFU) for prostate cancer ablation, revealed the approach to be effective in short-term control but not without toxicity. -
Meta-Analysis of Transplant for AML in CR1
Allogeneic hematopoietic cell transplantation (alloHCT) is recommended for consolidation among poor-risk AML patients in CR1, but controversy remains for intermediate-risk disease. -
Cerebrovascular Disease in Hodgkin Lymphoma Survivors
In a retrospective cohort study among 2,201 five-year survivors of Hodgkin lymphoma, there was a two- to three-fold increased risk of stroke and TIA. -
Triple-drug Neoadjuvant Therapy for Triple-negative Breast Cancer
For patients with ER-, PR-, HER 2- breast cancer, neoadjuvant treatment, with eight weekly cycles of cisplatin, epirubicin, and paclitaxel (and G-CSF), resulted in impressive response rates and promising long-term, disease-free survival. -
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch